China gives with one hand, and takes away with the other. This is the impression given in recent weeks, with the crackdown on pharmaceutical companies in China, accompanied by announcements of flagship Chinese investments in the UK in the shape of a new nuclear plant in western England and a business district at Manchester airport. GSK's loss is the UK's gain, especially if visa application rules for Chinese tourists are relaxed so that 'UK plc' wins a greater slice of China's multi-billion dollar expenditure on overseas travel.